Citigroup’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-76
| Closed | -$281 | – | 4885 |
|
|
2022
Q4 | $281 | Sell |
76
-911
| -92% | -$3.37K | ﹤0.01% | 4766 |
|
|
2022
Q3 | $1K | Sell |
987
-276
| -22% | -$280 | ﹤0.01% | 4837 |
|
|
2022
Q2 | $1K | Sell |
1,263
-10,051
| -89% | -$7.96K | ﹤0.01% | 5262 |
|
|
2022
Q1 | $10K | Sell |
11,314
-4,585
| -29% | -$4.05K | ﹤0.01% | 4755 |
|
|
2021
Q4 | $127K | Sell |
15,899
-13,385
| -46% | -$107K | ﹤0.01% | 3850 |
|
|
2021
Q3 | $245K | Sell |
29,284
-4,891
| -14% | -$40.9K | ﹤0.01% | 3299 |
|
|
2021
Q2 | $230K | Sell |
34,175
-1,851,440
| -98% | -$12.5M | ﹤0.01% | 3519 |
|
|
2021
Q1 | $12.5M | Buy |
+1,885,615
| New | +$12.5M | 0.01% | 920 |
|
|
2020
Q4 | – | Sell |
-3,964
| Closed | -$19K | – | 5263 |
|
|
2020
Q3 | $19K | Buy |
3,964
+95
| +2% | +$455 | ﹤0.01% | 3998 |
|
|
2020
Q2 | $24K | Sell |
3,869
-3,255
| -46% | -$20.2K | ﹤0.01% | 4140 |
|
|
2020
Q1 | $39K | Buy |
7,124
+3,296
| +86% | +$18K | ﹤0.01% | 3971 |
|
|
2019
Q4 | $38K | Buy |
3,828
+2,805
| +274% | +$27.8K | ﹤0.01% | 4147 |
|
|
2019
Q3 | $6K | Buy |
1,023
+120
| +13% | +$704 | ﹤0.01% | 4740 |
|
|
2019
Q2 | $8K | Buy |
903
+314
| +53% | +$2.78K | ﹤0.01% | 4799 |
|
|
2019
Q1 | $8K | Buy |
+589
| New | +$8K | ﹤0.01% | 4799 |
|
|
2015
Q4 | – | Sell |
-4
| Closed | – | – | 5598 |
|
|
2015
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 5457 |
|